Catapres

In some countries, this medicine may only be approved for veterinary use.

In the US, Catapres (clonidine systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat ADHD, Alcohol Withdrawal, Anxiety, Atrial Fibrillation, Benzodiazepine Withdrawal, Bipolar Disorder, High Blood Pressure, Hyperhidrosis, Hypertensive Emergency, Insomnia - Stimulant-Associated, Migraine Prevention, Opiate Withdrawal, Pain, Perimenopausal Symptoms, Persisting Pain - Shingles, Pheochromocytoma Diagnosis, Restless Legs Syndrome, Tourette's Syndrome and Ulcerative Colitis.

US matches:

• Catapres


• Catapres-TTS Patches


• Catapres-TTS-1 transdermal


• Catapres-TTS-2 transdermal


• Catapres-TTS-3 transdermal


• Catapres-TTS-1


• Catapres-TTS-2


• Catapres-TTS-3


• Catapres-TTS

UK matches:

• Catapres Ampoules
• Catapres Tablets
• Catapres Ampoules (SPC)
• Catapres Tablets 100mcg (SPC)
• Catapres Tablets 300mcg (SPC)

Ingredient matches for Catapres

Clonidine

Clonidine is reported as an ingredient of Catapres in the following countries:

• Ethiopia


• Ireland

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Catapres in the following countries:

• Australia


• Bahrain


• Canada


• Egypt


• Greece


• Guyana


• India


• Indonesia


• Iraq


• Ireland


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Libya


• New Zealand


• Qatar


• Saudi Arabia


• Sri Lanka


• Sudan


• Taiwan


• Thailand


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.